Yujiao Zu, Ph.D.

Research Interests

• Investigate interactions between dietary components and obesity-associated metabolic disorders, especially inflammation, insulin resistance and cardiovascular disease.
• Identify underlying mechanisms and regulations in obesity and related diseases using cells and animal models.
• Investigate effect of obesity and aging on immune and inflammatory diseases.
• Application of nanotechnology to obesity and aging related diseases

Selected Publications

Goktas Z, Zu Y, Abbasi M, Galyean S, Wu D, Fan Z, Wang S. Recent Advances in Nanoencapsulation of Phytochemicals to Combat Obesity and Its Comorbidities. Journal of Agricultural and Food Chemistry. 2020 Jul 7;68(31):8119-31.

Zhang J, Nie S, Zu Y, Abbasi M, Cao J, Li C, Wu D, Labib S, Brackee G, Shen CL, Wang S. Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles. Journal of Controlled Release. 2019 Jun 10;303:263-73.

Hao L, Scott S, Abbasi M, Zu Y, Khan MS, Yang Y, Wu D, Zhao L, Wang S. Beneficial metabolic effects of mirabegron in vitro and in high-fat diet-induced obese mice. Journal of Pharmacology and Experimental Therapeutics. 2019 Jun 1;369(3):419-27.

Zu Y, Overby H, Ren G, Fan Z, Zhao L, Wang S. Resveratrol liposomes and lipid nanocarriers: Comparison of characteristics and inducing browning of white adipocytes. Colloids and Surfaces B: Biointerfaces. 2018 Apr 1;164:414-23.

Chung E, Mo H, Wang S, Zu Y, Elfakhani M, Rios SR, Chyu MC, Yang RS, Shen CL. Potential roles of vitamin E in age-related changes in skeletal muscle health. Nutrition Research. 2018 Jan 1;49:23-36.

Zhang J, Zu Y, Dhanasekara CS, Li J, Wu D, Fan Z, Wang S. Detection and treatment of atherosclerosis using nanoparticles. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2017 Jan;9(1):e1412.